|11th November 2020||Kevin C Oboyle||16,306||Disposition due to a tender of shares in a change of control transaction||$30.75||$501,409.50|
|11th November 2020||Elizabeth H Weatherman||38,084||Disposition due to a tender of shares in a change of control transaction||$30.75||$1,171,083.00|
|10th November 2020||Niamh Louise Pellegrini||750||Open or private sale||$170.75||$128,062.50|
|10th November 2020||Niamh Louise Pellegrini||750||Exercise of derivative||$64.95||$48,712.50|
|1st November 2020||Kashif Rashid||2,192||Payment by withholding||$149.21||$327,068.32|
|22nd October 2020||Niamh Louise Pellegrini||1,817||Open or private sale||$165.00||$299,805.00|
|19th October 2020||Niamh Louise Pellegrini||1,000||Open or private sale||$155.00||$155,000.00|
|14th October 2020||Elizabeth H Weatherman||500||Grant/award etc.||$29.95||$14,975.00|
|13th October 2020||Niamh Louise Pellegrini||750||Exercise of derivative||$64.95||$48,712.50|
|13th October 2020||Niamh Louise Pellegrini||750||Open or private sale||$151.47||$113,602.50|
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 8/10.
Nevro Corp. engages in the provision of medical devices. The firm focuses on providing products that improve the quality of life of patients suffering from debilitating chronic pain.